Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.
Kobayashi E, Kamihara Y, Arai M, Wada A, Kikuchi S, Hatano R, Iwao N, Susukida T, Ozawa T, Adachi Y, Kishi H, Dang NH, Yamada T, Hayakawa Y, Morimoto C, Sato T.
Kobayashi E, et al. Among authors: dang nh.
Cells. 2023 Aug 14;12(16):2059. doi: 10.3390/cells12162059.
Cells. 2023.
PMID: 37626869
Free PMC article.